This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The Law Office Of Robbins Umeda LLP Announces An Investigation Of The Acquisition Of Prospect Medical Holdings, Inc. By An Entity Sponsored By Leonard Green & Partners, L.P.

Robbins Umeda LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the Board of Directors of Prospect Medical Holdings, Inc. ("Prospect" or the "Company") (NASDAQ: PZZ) in connection with their efforts to sell Prospect to an entity sponsored by Leonard Green & Partners, L.P. ("Leonard Green"). If the transaction is completed, Prospect shareholders will receive $8.50 in cash for each share of Prospect stock they hold.

Robbins Umeda LLP's investigation concerns whether the Board of Directors of Prospect undertook a fair process to obtain fair consideration for all shareholders of Prospect. Specifically, our investigation concerns whether the Company's Board of Directors breached their fiduciary duties to Prospect shareholders by failing to adequately shop the Company before entering into the transaction with an entity sponsored by Leonard Green. Notably, Prospect reported revenues of $116.7 million for the second quarter of 2010, a 36% increase from $86.1 million in the prior year quarter.

If you are a shareholder of Prospect, plan to continue to hold your shares, and would like more information about your rights as a shareholder, please contact attorney Gregory E. Del Gaizo at 800-350-6003 or by e-mail at info@robbinsumeda.com.

Robbins Umeda LLP is a California-based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions. For more information about the firm, please go to http://www.robbinsumeda.com.

Advertisement

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
AAPL $127.60 0.00%
GOOG $535.38 0.00%
FB $83.09 0.00%
YHOO $44.66 0.00%
TSLA $205.27 0.00%

Markets

DOW 18,034.93 +208.63 1.17%
S&P 500 2,100.40 +19.22 0.92%
NASDAQ 4,994.6020 +62.7870 1.27%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs